M William, Basem; Woost, Philip; Mahfouz, Reda; Brister, Lauren; Caimi, Paolo; Campagnaro, Erica; Cooper, Brenda; M Lazarus, Hillard; Saunthararajah, Yogen; JG de Lima, Marcos; V Komanduri, Krishna; Jacobberger, James
(ELSEVIER, 2015)
Disease relapse is a major cause of treatment failure following alloSCT for acute myeloid leukemia (AML). Azacitidine has shown efficacy in treating, and preventing, post-transplant relapse in patients with AML. Post-SCT ...